function by Ra C Mcpherron et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Developmental Biology
Open Access Research article
Redundancy of myostatin and growth/differentiation factor 11 
function
Alexandra C McPherron*1, Thanh V Huynh2 and Se-Jin Lee*2
Address: 1Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of 
Health, 9000 Rockville Pike, Bethesda, MD 20892, USA and 2Department of Molecular Biology and Genetics, Johns Hopkins University School 
of Medicine, 725 North Wolfe Street, Baltimore, MD 21205, USA
Email: Alexandra C McPherron* - mcpherrona@niddk.nih.gov; Thanh V Huynh - thuynh@jhmi.edu; Se-Jin Lee* - sjlee@jhmi.edu
* Corresponding authors    
Abstract
Background: Myostatin (Mstn) and growth/differentiation factor 11 (Gdf11) are highly related
transforming growth factor β (TGFβ) family members that play important roles in regulating
embryonic development and adult tissue homeostasis. Despite their high degree of sequence
identity, targeted mutations in these genes result in non-overlapping phenotypes affecting distinct
biological processes. Loss of Mstn in mice causes a doubling of skeletal muscle mass while loss of
Gdf11 in mice causes dramatic anterior homeotic transformations of the axial skeleton, kidney
agenesis, and an increase in progenitor cell number in several tissues. In order to investigate the
possible functional redundancy of myostatin and Gdf11, we analyzed the effect of eliminating the
functions of both of these signaling molecules.
Results: We show that Mstn-/- Gdf11-/- mice have more extensive homeotic transformations of the
axial skeleton than Gdf11-/- mice in addition to skeletal defects not seen in single mutants such as
extra forelimbs. We also show that deletion of Gdf11 specifically in skeletal muscle in either Mstn+/
+ or Mstn-/- mice does not affect muscle size, fiber number, or fiber type.
Conclusion: These results provide evidence that myostatin and Gdf11 have redundant functions
in regulating skeletal patterning in mice but most likely not in regulating muscle size.
Background
Myostatin (Mstn) and growth/differentiation factor 11
(Gdf11) are highly related members of the transforming
growth factor β (TGFβ) superfamily of secreted growth
and differentiation factors. Like other TGFβ family mem-
bers, myostatin and Gdf11 precursor proteins are proteo-
lytically processed to form biologically-active carboxy-
terminal dimers. Myostatin and Gdf11 share 90% amino
acid identity in this carboxy-terminal region which places
them in their own TGFβ family subgroup. They also have
similar signaling pathways; both bind the activin type IIB
receptor (Acvr2b, also known as ActRIIB) and activate the
intracellular mediator Smad 2/3 pathway [1-5], and both
are antagonized by follistatin, a secreted glycoprotein that
can bind several TGFβ family members [2,6-9].
Mstn is predominantly expressed in developing and adult
skeletal muscle [10]. We previously reported the disrup-
tion of the Mstn  gene by gene targeting in mice and
showed that myostatin normally functions as a negative
regulator of skeletal muscle mass [10]. Most Mstn-/- mus-
cles are approximately double the mass of Mstn+/+ muscles
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due to both hyperplasia and hypertrophy of myofibers
[10]. Subsequently, naturally occurring Mstn gene muta-
tions were found in cattle, dogs, sheep, and one child with
increased muscle mass indicating conservation of myosta-
tin function in mammals [11]. Injection of myostatin
antagonists also causes a significant increase in muscle
mass in normal and dystrophic adult mice demonstrating
that myostatin function is not restricted to developmental
stages [12-17]. These results suggest that inhibition of
myostatin may be a promising therapeutic target for treat-
ing muscle wasting diseases.
We also reported the deletion of the Gdf11 gene by gene
targeting in mice [18]. In contrast to Mstn-/- mice, Gdf11-/-
mice display anterior homeotic transformations of the
axial skeleton wherein the identity of posterior vertebrae
are transformed into those of more anterior vertebrae
[18]. Anterior/posterior (A/P) axial mesoderm identity is
thought to be established by differential combinatorial
expression of Hox genes that are induced as cells move
through the primitive streak during gastrulation [19].
Consistent with this model, Gdf11 is strongly expressed in
the primitive streak and tail bud [7,18,20], and Gdf11-/-
mice have altered Hox gene expression along the A/P axis
[18]. In addition to the axial skeleton, defects in Gdf11-/-
mice are found in other tissues where Gdf11 is expressed.
For instance, Gdf11-/- mice have renal agenesis, an increase
in the number of islet progenitors in the pancreas, an
increase in the number of neurons and neuronal progeni-
tors in the olfactory epithelium, and an increase in the
number of retinal ganglion cells and reduction in the
number of photoreceptors and amacrine cells in the retina
[21-25].
Although the phenotypes caused by each gene disruption
appear to be non-overlapping, the high sequence identity
and similarity in signaling mechanisms suggest the two
factors may be functionally redundant. In addition, Mstn
is expressed transiently in the primitive streak in the chick
[26]. We therefore decided to test whether myostatin has
a role in determining A/P positional identity of the axial
skeleton. In a similar vein, Gdf11 has been shown to
inhibit myogenesis in chick limb mensenchyme cultures
[27], so we also sought to test whether Gdf11 has a role in
regulating skeletal muscle mass. Our data show that
myostatin and Gdf11 have redundant functions in regu-
lating skeletal patterning in mice but most likely not in
regulating muscle size.
Results and discussion
Skeletal patterning in Mstn-/- Gdf11-/- mice
We crossed double heterozygous mice (Mstn+/- Gdf11+/-)
to produce Mstn-/- Gdf11-/- mice to examine redundancy of
myostatin and Gdf11 function during development. Mstn-
/- Gdf11-/- mice were born at the expected ratio (data not
shown), but none were found alive. While most Gdf11-/-
mutants have renal agenesis and cleft palate [22], these
phenotypes were fully penetrant in Mstn-/- Gdf11-/- mice.
To analyze skeletal alterations in double mutants, we per-
formed skeleton preps on newborn mice to determine ver-
tebral identity. Wild-type mice commonly have 13 thoracic
and 6 lumbar vertebrae while Gdf11-/- mice typically have
18 thoracic and 8 lumbar vertebrae [18]. Gdf11-/- offspring
from crosses of double heterozygotes had 17–19 thoracic
and 7–9 lumbar vertebrae as expected (Tables 1 and 2, Fig-
ure 1A). In contrast, skeletons of Mstn-/- mice had a similar
pattern as the majority of wild-type mice with 13 thoracic
and 6 lumbar vertebrae (Tables 1 and 2). Deletion of one
allele of Mstn in Gdf11-/- mice (Mstn+/- Gdf11-/-) also had
no effect on thoracic or lumbar vertebral number in com-
parison with Gdf11-/- mice (Tables 1 and 2). Loss of both
alleles of Mstn  in Gdf11-/- mice, however, resulted in a
much more severe phenotype. Most Mstn-/- Gdf11-/- mice
had 20 rather than 18 thoracic vertebrae although in 4 out
Skeletal defects in Mstn-/- Gdf11-/- newborn mice Figure 1
Skeletal defects in Mstn-/- Gdf11-/- newborn mice. Tho-
racic region of Gdf11-/- (A) and Mstn-/- Gdf11-/- (B) mutants 
showing the increase in rib number. Note that the anterior 
homeotic transformations of thoracic vertebrae are more 
extensive in the Mstn-/- Gdf11-/- mutant (20 ribs) versus the 
single Gdf11-/-mutant (18 ribs). Whole skeleton preparation 
of Gdf11-/- (C) and Mstn-/- Gdf11-/- (D) pups. (E) Ventral torso 
of newborn double mutant showing multiple projections 
from the skin (*) and an extra limb (arrowhead). Forelimb 
skeleton preparations of Gdf11-/- (F) and Mstn-/- Gdf11-/- (G 
and H) pups showing an extra bone emanating from the 
shoulder of the double mutant (G, arrow) and an extra limb 
(H). The limb in (G) has been rotated for a better view of the 
extra bone. (I and J) Hindlimb phenotypes of Mstn-/- Gdf11-/- 
pups. Note the truncation of the vertebral column (I) and 
malformation of the ilieum and all leg bones (J).BMC Developmental Biology 2009, 9:24 http://www.biomedcentral.com/1471-213X/9/24
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of 17 double mutant pups the transformations were even
more dramatic (Figure 1B, Table 1). In these 4 mice, the
most posterior thoracic vertebra was asymmetric with a
21st rib on one side and a lumbar-like phenotype on the
other (Table 1 and 2). The extent of the anterior homeotic
transformations in the thoracic region of Mstn-/- Gdf11-/-
mice were greater than any we have seen in Gdf11-/- mice.
The skeletal regions posterior to the thoracic region were
also altered in mutant mice. As previously described [18],
the sacral vertebrae were present in Gdf11-/- mice, but the
axis was truncated in the caudal region resulting in an
overall decrease in the number of vertebral segments and
the loss of most of the tail with only a few deformed ver-
tebrae remaining (Figure 1C). In Mstn-/- Gdf11-/- mice,
there were even fewer post-thoracic vertebrae with an
average of 10 post-thoracic segments, the most posterior
of which were malformed (Figure 1D and 1I). The sacral
vertebrae were not identifiable in Mstn-/- Gdf11-/- mice
making it difficult to tell which vertebra was the most pos-
Table 1: Thoracic vertebral number from newborn mice
Genotype
Mstn +/+ +/+ +/+ +/- +/- +/- -/- -/- -/-
Gdf11 +/+ +/- -/- +/+ +/- -/- +/+ +/- -/-
Total number of thoracic vertebrae Number of animals
13 10 - - 10 - - 10 1 -
14 - 10 - - 10 - - 9 -
1 5 ---- - - - - -
1 6 ---- - - - - -
1 7 ---- - - - - -
1 7 + 1 8 - -1-- --- -
18 - - 8 - - 7 - - -
1 8 + 1 9 ---- - 1 - - -
19 - - 1 - - 2 - - 1
1 9 + 2 0 ---- - - - - 1
2 0 ---- - - - - 1 1
2 0 + 2 1 ---- - - - - 4
Numbers of mice displaying a given number of vertebrae are shown. Some mice have left-right asymmetry of the most posterior thoracic vertebra 
with a rib on one side and a lumbar phenotype on the other. These are designated by a + sign between 2 numbers indicating the number of ribs for 
each side.
Table 2: Lumbar vertebral number from newborn mice
Genotype
Mstn +/+ +/+ +/+ +/- +/- +/- -/- -/- -/-
Gdf11 +/+ +/- -/- +/+ +/- -/- +/+ +/- -/-
Total number of lumbar vertebrae Number of animals
5 3- -3- ---
5 + 6 1- - -- ---
66 1 0 - 7 1 0 - 1 0 9
6 + 7 - - - -- ---
7- - 1 - - 1 - 1
7 + 8 - -1-- ---
8- - 5 - - 5 - -
8 + 9 - -2-- ---
9- - 1 - - 3 - -
9 + 1 0 ---- - 1 - -
Numbers of mice displaying a given number of vertebrae are shown. Some mice have left-right asymmetry of the most posterior lumbar vertebra 
with a lumbar phenotype on one side and a sacral phenotype the other. These are designated by a + sign between 2 numbers indicating the number 
of vertebrae possessing a lumbar appearance for each side. Asymmetric vertebrae with a thoracic and lumbar phenotype were counted as thoracic 
(Table 1). Number of lumbar vertebrae could not be determined for Mstn-/- Gdf11-/- mice.BMC Developmental Biology 2009, 9:24 http://www.biomedcentral.com/1471-213X/9/24
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terior lumbar vertebra (Figure 1I). The increase in severity
of the Gdf11 null phenotype throughout the vertebral axis
in the absence of Mstn demonstrates that myostatin and
Gdf11 play redundant roles in patterning and develop-
ment of the axial skeleton.
Mstn-/- Gdf11-/- pups also had other skeletal defects not
seen in Gdf11-/- mutants. The frontal bones curved anteri-
orly to meet the nasal bone which gave the skull vault a
rounded shape compared to Gdf11-/- mice (Figure 1C and
1D and Additional file 1A and 1B: Cranial and forelimb
digit skeletal defects in Mstn-/- Gdf11-/- newborn mice).
Although Gdf11 is expressed in the developing limb buds
[7,20], no defects were detected in limbs of Gdf11-/-
mutants (Figure 1C and 1F). Mstn-/- Gdf11-/- mice, how-
ever, had severe limb defects. Many Mstn-/- Gdf11-/- mice
had small projections emanating from the skin on the
ventral surface of the torso, some of which were filled with
a single rod of cartilage (Figure 1E). In Mstn-/- Gdf11-/-
mutants, the long bones of the forelimb were shortened
relative to those in Gdf11-/- mice and, in 9 out of 18 dou-
ble mutants, an extra bone projected from shoulder (Fig-
ure 1F and 1G). The most surprising result was a third
limb that resembled a forelimb composed of a single uni-
dentifiable long bone with attached digits (Figure 1E and
1H). This phenotype was found in 6 out of 18 double
mutants, two of which also had an extra bone on the con-
tralateral shoulder. In all Mstn-/- Gdf11-/- mutants, the fore-
limbs in the normal position displayed digital patterning
defects including a sixth digit, which appeared to be simi-
lar to digit V, and syndactyly of digits III and IV consistent
with the expression of Gdf11  in the interdigital region
where programmed cell death would normally occur
[7,20] (Figure 1G and Additional file 1C and 1D: Cranial
and forelimb digit skeletal defects in Mstn-/- Gdf11-/- new-
born mice). No other genotypes displayed any of these
limb defects.
The hindlimbs in Mstn-/- Gdf11-/- mice displayed very dif-
ferent malformations than the forelimbs. The hindlimbs
were small and deformed although what appeared to be
elements of both proximal and distal structures, pelvic
bones, long bones, and digits, were seen in most double
mutants (Figure 1D, I and 1J). These results suggest some
proximal/distal patterning was maintained despite inhibi-
tion of hindlimb bud outgrowth.
This is the first demonstration that myostatin and Gdf11
are both required for limb development and axial skeletal
development and patterning. The effects of deletion of
both factors on the axial skeleton was greater than for loss
of Gdf11 alone most likely due to the transient expression
of Mstn in the posterior primitive streak overlapping with
Gdf11 expression [26]. We presume that the extra limbs
seen in the double mutant mice result from an expansion
of the limb field, but clearly additional studies will be
required to fully understand the molecular basis for the
formation of the extra limb buds.
Skeletal muscle in Gdf11 mutants
We also sought to determine whether myostatin and
Gdf11 are functionally redundant with respect to control
of muscle mass. The increase in muscle mass in Mstn-/-
mice is not present at birth (A.C.M. and S-J.L., unpub-
lished observations) so the neonatal death of Gdf11-/- and
Mstn-/- Gdf11-/- mice precludes a comparison of the skele-
tal muscle phenotype. We therefore generated a targeting
construct containing a conditional deletion allele of the
Gdf11  gene by inserting loxP recombination sites into
intron 1 and flanking a neo gene downstream of the Gdf11
3' UTR (Gdf11flox-neo) (Figure 2A and 2B). Following
homologous recombination in embryonic stem (ES) cells
and injection of the targeted cells into blastocysts, we
obtained chimeric mice that transmitted the Gdf11flox-neo
allele through the germline. Mice carrying the Gdf11flox-neo
allele were then crossed to EIIa-Cre transgenic mice to gen-
erate  Gdf11flox/+  mice carrying one upstream and one
downstream  loxP site after removal of the neo  gene.
Recombination at the remaining loxP sites would be pre-
dicted to delete exons 2 and 3 (Gdf11Δ2–3), which would
remove the biologically-active carboxy-terminal domain.
To demonstrate that recombination of loxP sites produced
a null allele, we generated germline recombination of loxP
sites in Gdf11flox/+ mice (Gdf11Δ2–3/+). Skeletal analysis per-
formed on offspring from Gdf11Δ2–3/+ matings showed
that Gdf11Δ2–3/+ and Gdf11Δ2–3/Δ2–3 mice had 1 and 5 extra
thoracic vertebrae, respectively (data not shown). These
thoracic vertebral numbers are identical to that of Gdf11+/
- and Gdf11-/- mice [18] confirming that recombination of
loxP sites in the Gdf11flox allele results in a null allele.
For skeletal muscle-specific recombination of loxP
sequences, a Cre deletor transgenic line was made using
the myosin light chain 1/3 promoter/enhancer (MLC-Cre)
(Figure 2A). As expected, Cre expression in this line was
restricted to skeletal muscle (Figure 2C). MLC-Cre mice
were crossed to Gdf11flox/+ mice and then backcrossed to
Gdf11flox/+ mice or crossed to Gdf11+/- from the original
knockout line. Recombination of Gdf11flox was detected
specifically in skeletal muscle genomic DNA (Figure 2D).
In  Gdf11flox/-  muscle, Cre-mediated recombination
resulted in a near complete reduction in skeletal muscle
Gdf11 expression (Figure 2E).
Body weight and muscle mass were measured in all 8 pos-
sible genotypes produced from crosses of Gdf11flox/+ MLC-
Cre and Gdf11+/- mice. There were no differences in body
weight or muscle mass between Gdf11+/+, Gdf11+/+ MLC-
Cre, Gdf11+/-, Gdf11+/- MLC-Cre, Gdf11flox/+, or Gdf11flox/+
MLC-Cre mice demonstrating that there was no hetero-BMC Developmental Biology 2009, 9:24 http://www.biomedcentral.com/1471-213X/9/24
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zygous or transgene phenotype (data not shown). We next
performed an examination of the muscle phenotype of
Gdf11flox/- and Gdf11flox/- MLC-Cre mice. There was no sta-
tistically significant difference in body weight or muscle
mass between Gdf11flox/-  and  Gdf11flox/-  MLC-Cre  mice
(data not shown and Figure 3A).
Skeletal muscles vary in their composition of fiber types
which differ in metabolic and contractile properties [28].
In mice, type I fibers are slow contracting and oxidative,
type IIB fibers are fast contracting and glycolytic, and type
IIA and IID/X fibers are intermediate in phenotype. Mstn-
/- mice have an overall increase in the number of muscle
Muscle-specific targeting of Gdf11 gene Figure 2
Muscle-specific targeting of Gdf11 gene. (A) Representation of targeting strategy. The 3 exons are shown as boxes with 
coding sequences shaded black and the 3'UTR open. The targeting construct is represented by a thick line which contains loxP 
sequences with EcoRI restriction sites inserted into the second XbaI site in exon 1 and flanking a neo gene inserted into the 
EcoRI site downstream of the 3'UTR. Cre-mediated recombination of the loxP sites flanking the neo gene results in a Gdf11flox 
allele. Recombination of the Gdf11flox allele generates the Gdf11Δ2–3 allele. Oligonucleotide primers used for distinguishing alleles 
are labeled a, b, and c. A skeletal muscle-specific Cre expressing transgene was constructed using the MLC1 promoter/1/3 
enhancer and an SV40 t antigen intron and poly adenylation signal. (B) Southern blot showing detection of Gdf11+, Gdf11flox, and 
Gdf11-(null, from the original knockout line) alleles. (C) Northern blot analysis of MLC-Cre transgene expression in pectoralis 
and quadriceps muscles but not in other tissues. (D) Detection of Gdf11 alleles in genomic DNA in Gdf11flox/floxand Gdf11flox/
floxMLC-Cre mice by PCR (right panel). Recombination was detected in quadriceps and pectoralis muscles of Gdf11flox/floxMLC-Cre 
mice but not in heart, brain, or kidney. No recombination was seen in Gdf11flox/floxmice. Left panel shows control reactions. (E) 
Northern blot analysis of skeletal muscle Gdf11 expression showing a strong decrease in expression in Gdf11flox/-MLC-Cre mus-
cle compared to Gdf11flox/-muscle.
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fibers and alterations in the proportions of the different
fiber types compared to Mstn+/+ mice resulting in a shift
toward more glycolytic muscle [10,29,30]. To determine
whether Gdf11 regulates fiber number or type, we
counted the number of each of the four fiber types in
Gdf11flox/- and Gdf11flox/- MLC-Cre mice from the widest
part of each muscle. We chose a fast muscle, the extensor
digitorum longus (EDL), and a slow muscle, the soleus,
for analysis because they have been previously shown to
have alterations in fiber number and type in Mstn-/- mice
[29,30]. Unlike muscle in Mstn-/- mice, there was no differ-
ence in the total number of fibers in either the EDL or the
soleus muscles between Gdf11flox/- and Gdf11flox/- MLC-Cre
mice (Figure 3B and 3C). Fiber type composition in
Gdf11flox/- and Gdf11flox/- MLC-Cre  mice was not signifi-
cantly different either (Figure 3B and 3C).
Because a role for myostatin in axial skeletal patterning
was found only in the absence of Gdf11, we asked
whether a phenotype caused by loss of Gdf11 in muscle
might be present in the absence of myostatin. Mstn-/-
Gdf11flox/flox mice were crossed to Mstn-/- Gdf11flox/flox MLC-
Cre mice, and body weight and muscle mass were meas-
ured in offspring at 8 weeks and 6 months of age. There
were no significant differences in body weight or muscle
mass found between genotypes at either age (data not
shown and Figure 3A). Next, we determined fiber number
and fiber composition. There were no significant differ-
ences in the total number of fibers or in the number of
individual fiber types in EDL or soleus between Mstn-/-
Gdf11flox/flox and Mstn-/- Gdf11flox/flox MLC-Cre mice (Figure
3B and 3C).
Our results provide evidence that that myostatin and
Gdf11 have redundant functions in regulating skeletal
development and patterning but not skeletal muscle size.
We certainly cannot rule out the possibility that sufficient
Gdf11 function is maintained by the small amount of
Gdf11 expression remaining in the mutant muscles or that
Gdf11 may have a function in developing skeletal muscle
at early stages of development prior to activation of the
MLC promoter. Gdf11 is detectable in serum [31] so we
also cannot rule out the possibility that Gdf11 produced
by other tissues not affected by muscle-specific recombi-
nation contributes to muscle mass regulation.
Nevertheless, the lack of an effect of these genetic manip-
ulations of Gdf11 signaling on muscle mass was some-
what unexpected because myostatin and Gdf11 are highly
homologous and because the function of myostatin in
regulating skeletal muscle mass is clearly redundant with
that of other TGFβ family members. Injection of a soluble
Acvr2b receptor causes a 20% increase in muscle mass in
Mstn-/- mice demonstrating that at least one other ligand
in addition to myostatin is a negative regulator of skeletal
muscle size [15]. This other Acvr2b-binding ligand(s)
must also be inhibited by follistatin; Mstn-/- mice have
double the muscle mass of Mstn+/+ mice while Mstn-/- mice
overexpressing a muscle-specific follistatin transgene have
quadruple the skeletal muscle mass of Mstn+/+ mice [32].
Several other TGFβ superfamily members are potential
candidates for myostatin functional redundancy. In addi-
tion to Gdf11, other family members, such as the activins
and some bone morphogenetic proteins, bind Acvr2b and
follistatin [31,33-36]. Myostatin, Gdf11, activin, and
some BMPs can be isolated from serum using Acvr2b
affinity purification [31]. The affinity of the BMPs for fol-
Muscle weight, fiber number, and fiber type in skeletal mus- cle-specific Gdf11 mutant mice in a Mstn wild-type or null  background Figure 3
Muscle weight, fiber number, and fiber type in skele-
tal muscle-specific Gdf11 mutant mice in a Mstn wild-
type or null background. (A) Weight of pectoralis, tri-
ceps, quadriceps, gastrocnemius/plantaris, and tibialis ante-
rior muscles (n = 7–12). (B) Number of total, IIA, IID/X, and 
IIB fibers in the EDL muscle (n = 3–4). EDL muscles had on 
average less than 4 type I fibers in all genotypes so type I data 
are not shown. (C) Number of total, type I, IIA, IID/X, and 
IIB fibers in the soleus muscle (n = 3–5). Skeletal muscle-spe-
cific Gdf11 deletion had no effect on muscle mass, fiber 
number, or fiber type unlike Mstn deletion (*P < 0.05, †P < 
0.01, ‡P < 0.001). Data are mean ± s.e.
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listatin, however, is considerably lower than that of
activin, myostatin, and Gdf11 [8,9]. Additionally, the
activins inhibit differentiation of C2C12 myoblasts and
skeletal muscle precursors in the chick limb and would
therefore be likely candidates for functional redundancy
with myostatin [31,37]. It is also possible there are multi-
ple TGFβ family members that are negative regulators of
muscle mass in addition to myostatin that individually
have only small effects on muscle growth. If so, deletion
or inhibition of these factors might cause a measurable
increase in muscle mass only in the absence of myostatin
and other redundant ligands.
Not only are the ligands redundant, myostatin and Gdf11
receptor function is also redundant. Although the affinity
of myostatin for activin type II receptor (Acvr2, also
known as ActRIIA) is low [2,5], Acvr2-/- mice, like Acvr2b-/
- mice, have a small increase in skeletal muscle mass rela-
tive to Mstn-/- mice [15]. This suggests that both Acvr2 and
Acvr2b are receptors for myostatin in vivo. Similarly,
Acvr2b-/- mice have anterior homeotic transformations of
the axial skeleton that are milder than those seen in Gdf11-
/- mice [38]. The Acvr2+/- Acvr2b-/- axial skeletal pattern
closely phenocopies that of Gdf11-/- mice [3] suggesting
that both Acvr2 and Acvr2b are receptors for Gdf11. These
data suggest therapeutic strategies that target both Acvr2
and Acvr2b receptor function or myostatin and other
TGFβ growth factors with similar functions would lead to
greater increases in muscle mass than targeting either
Acvr2b or myostatin alone.
Conclusion
Our results demonstrate that myostatin and Gdf11 have
redundant functions in regulating skeletal patterning in
mice. We did not, however, find evidence that Gdf11 is
the TGFβ family member that is redundant to myostatin
in regulation of skeletal muscle size. To determine the
therapeutic strategy that results in the greatest potential
increase in muscle mass, it will be important to identify
the other TGFβ family members that negatively regulate
skeletal muscle mass.
Methods
RNA isolation, Northern analysis
Total RNA was isolated from 8 week old animals from a
pool of pectoralis, quadriceps, triceps, gastrocnemius,
plantaris, and tibialis anterior muscles using Trizol rea-
gent (Invitrogen). PolyA+ RNA was isolated from total
RNA using an Oligotex mRNA kit (Qiagen). For Northern
blot analysis, 5 μg mRNA was electrophoresed, blotted to
GeneScreen Plus (Perkin Elmer), and hybridized accord-
ing to the manufacturer's instructions using a probe corre-
sponding to the carboxy-terminal region of Gdf11 in exon
3. After the signal decayed, the same blot was probed with
Gapdh as a loading control.
Muscle-specific targeting of Gdf11
All animal experiments were approved by the Institu-
tional Animal Care and Use Committees of the Johns
Hopkins University School of Medicine or NIDDK. To
make muscle-specific Cre  expressing mice, the coding
sequence of Cre recombinase modified to contain Kozak
consensus sites was inserted into the MDAF2 vector con-
taining the myosin light chain promoter and 1/3
enhancer and SV40 processing sites [39]. To make the
Gdf11  conditional allele, 3 loxP sites were inserted in
intron 1 and flanking a neo gene downstream of the 3'
UTR (Figure 2A) and used to replace the endogenous
locus by gene targeting in ES cells. Microinjections and
blastocyst injections were carried out by the Johns Hop-
kins School of Medicine Transgenic Core Facility. Off-
spring of male Gdf11flox-neo/+ chimeras mated to C57BL/6
females were crossed to EIIa-Cre transgenic mice in the
FVB background (The Jackson Laboratory) to generate
males mosaic for loxP recombinations [40]. These males
were mated to C57BL/6 females and screened by PCR for
loss of the neo gene and retention of Gdf11 exons 2 and 3
(Gdf11flox/+). Gdf11flox/+ mice were crossed once more to
C57BL/6 mice, and EIIA-Cre negative Gdf11flox/+ mice were
crossed to MLC-Cre mice to generate Gdf11flox/+ MLC-Cre
mice. Gdf11flox/+ MLC-Cre mice were mated to Gdf11+/- in a
129/Sv genetic background from the original knockout
line and to Mstn+/- in the C57BL/6 genetic background.
Gdf11flox/+Mstn+/- MLC-Cre mice were crossed to Gdf11flox/
+Mstn+/- mice to generate Mstn-/- Gdf11flox/flox and  Mstn-/-
Gdf11flox/flox MLC-Cre mice which were interbred to pro-
duce animals for analysis. To show that Gdf11Δ2–3 is a null
allele, Gdf11Δ2–3/+ mice with germline recombination of
the Gdf11flox allele were obtained using Cre/Esr1 mice [41]
purchased from The Jackson Laboratory.
Genotyping
ES cell targeting and F1 offspring were analyzed by South-
ern blot after EcoRI digestion of genomic DNAs using the
same probe as in ref. 18. EcoRI fragment sizes were 6.5 kb
for wild-type and 2.5 kb targeted Gdf11 flox-neo alleles. Loss
of the neo cassette after crosses to EIIA-Cre mice was deter-
mined by PCR using primers b and c. Gdf11flox, Gdf11Δ2–3,
and Gdf11+ alleles were detected by PCR using one reac-
tion containing primers a, b, and c. Cre lines and Mstn
alleles in crosses between Mstn+/- and Gdf11flox/+ mice were
genotyped by PCR. All PCR was carried out at an anneal-
ing temperature of 55°C in buffer containing 10 mM Tris,
pH 8.8, 25 mM KCl, 1.5 mM MgCl2, 0.2 mM of each
dNTP, and 0.8 μM of each oligonucleotide primer. Oligo-
nucleotide primers used and product sizes: Cre, 505 bp, 5'
CCGAAATTGCCAGGATCAGGG 3' (forward) and 5'
TCGCCATCTTCCAGCAGGCGC 3' (reverse); Mstn+, 220
bp, 5'-AGAAGTCAAGGTGACAGACACAC-3' (forward)
and 5'-GGTGCACAAGATGAGTATGCGG-3' (reverse);
Mstn  null (in PGK neo cassette), 332 bp, 5'-GGATCG-BMC Developmental Biology 2009, 9:24 http://www.biomedcentral.com/1471-213X/9/24
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GCCATTGAACAAGATG-3' (forward) and 5'-GAGCAAG-
GTGAGATGACAGGAG-3' (reverse); Gdf11  alleles,
Gdf11flox a/c = 300 bp, Gdf11+ b/c = 359 bp, Gdf11Δ2–3 b/c
= 393 bp, (a) 5'ATGCAGATGGTAATACTTGGG3', (b) 5'-
AAGGCTTGGGAAGCAGGCAAG-3', and (c) 5'-AGGTAT-
GGTTAGGGTGTGGAG-3'. Gdf11 alleles were genotyped
by Southern blot for crosses between the Gdf11 null allele
from the original knockout line and Gdf11flox/+ MLC-Cre.
Genotyping of offspring from Mstn+/- Gdf11+/- crosses were
performed by Southern blot as described [10,18].
Analysis of muscles and skeletons
Soleus and EDL muscles from 8 week old (Gdf11flox/-,
Gdf11flox/-  MLC-Cre,  Gdf11flox/flox, and Gdf11flox/flox  MLC-
Cre) or 13 week old (Mstn+/+ and Mstn-/-) mice were frozen
and 12 μm cryostat sections were taken as described [10].
Fibers were counted from the widest part of the muscle
belly from H/E (soleus) or trichrome (EDL) stained sec-
tions. Fiber typing was done on adjacent sections. Primary
antibodies were used as dilutions of supernatants from
hybridoma cell lines (American Type Culture Collection)
and detected with the M.O.M. Peroxidase Kit (Vector Lab-
oratories). Cell lines, dilutions, and fiber types detected
were as follows: BA-D5, 1:30, type I; SC-71, 1:5, type IIA;
BF-F3, 1:1, type IIB; N2.261, 1:5 plus BF-F3, 1:1,
unstained type IID/X. Skeletons of newborn mice were
stained as described [18].
Statistical analysis
Body weight and muscle weights for the eight different
genotypes produced from crosses between Gdf11flox/+
MLC-Cre and Gdf11+/- mice were analyzed by single-factor
ANOVA with genotype as the factor and were considered
significant if P < 0.05. All other comparisons between two
genotypes were analyzed by Student's t-test.
Abbreviations
Acvr2: activin type II receptor; Acvr2b: activin type IIB
receptor; Gdf11: growth/differentiation factor 11; MLC:
myosin light chain; Mstn: myostatin; TGFβ: transforming
growth factor β.
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